Synthetic lipid nanoparticles targeting steroid organs

J Mérian, R Boisgard, X Decleves… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Lipidots are original nanoparticulate lipid delivery vectors for drugs and contrast agents
made from materials generally regarded as safe. Here, we characterized the in vivo stability …

99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution

S Ballot, N Noiret, F Hindré, B Denizot, E Garin… - European journal of …, 2006 - Springer
Purpose This study focusses on a promising carrier system for imaging and therapeutic
purposes using lipid nanocapsules. To assess their potential for clinical use, we labelled …

Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals

A Helbok, C Decristoforo, G Dobrozemsky… - Journal of liposome …, 2010 - Taylor & Francis
Radiolabeling of nanoparticles (NPs) has been performed for a variety of reasons, such as
for studying pharmacokinetics, for imaging, or for therapy. Here, we describe the in vitro and …

A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles

S Mannucci, F Boschi, B Cisterna… - International Journal …, 2020 - Taylor & Francis
Purpose Solid lipid nanoparticles are largely used in biomedical research and are
characterized by high stability and biocompatibility and are also able to improve the stability …

[HTML][HTML] Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

YQ Zhao, LJ Li, EF Zhou, JY Wang, Y Wang… - Pharmaceutical …, 2022 - thieme-connect.com
Lipid-based nanocarriers have been extensively investigated for drug delivery due to their
advantages including biodegradability, biocompatibility, nontoxicity, and …

Biodistribution of nanostructured lipid carriers (NLCs) after intravenous administration to rats: influence of technological factors

A Beloqui, MA Solinís, A Delgado, C Evora… - European journal of …, 2013 - Elsevier
Nanoparticles for medical applications are frequently administered via parenteral
administration. In this study, the tissue distribution of three lipid formulations based on …

Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy

L Aranda-Lara, E Morales-Avila… - Chemistry and Physics …, 2020 - Elsevier
Radiolabeled lipidic nanoparticles, particularly liposomes and lipoproteins, are of great
interest as agents for imaging and therapy, due not only to their peculiar physicochemical …

Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications

B Maddiboyina, Ramaiah… - Chemical Biology & …, 2023 - Wiley Online Library
Numerous nanotech arenas in therapeutic biology have recently provided a scientific
platform to manufacture a considerable swath of unique chemical entities focusing on drugs …

Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and γ counting

A Cahouet, B Denizot, F Hindre, C Passirani… - International journal of …, 2002 - Elsevier
The aim of the present work was to study the biodistribution of a radiolabeled lipidic
nanocapsule formulation after intravenous administration in rat by scintigraphy and γ …

Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution

A Beloqui, MÁ Solinís, A Delgado, C Évora… - Journal of …, 2014 - Taylor & Francis
The aim of this study was to develop a nanostructured lipid carriers (NLC) formulation
containing spironolactone (SPN-NLCs), and to investigate its potential for the oral delivery of …